Tectonic Therapeutic (TECX) Retained Earnings (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Retained Earnings of $474.2 million for Q4 2025, up 5268344.44% year-over-year from N/an in Q4 2024, and up 333.0% quarter-over-quarter from -$203.5 million in Q3 2025.
Tectonic Therapeutic (TECX) Retained Earnings (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Retained Earnings for 9 consecutive years, with $474.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Retained Earnings rose 5268344.44% year-over-year to $474.2 million; the TTM figure through Dec 2025 stood at $474.2 million (up 5268344.44% YoY), while the FY2025 annual figure was $474.2 million, up 5268344.44% from the prior year.
- Retained Earnings climbed to $474.2 million in Q4 2025 per TECX's latest filing, from -$203.5 million in the prior quarter.
- Across five years, Retained Earnings topped out at $474.2 million in Q4 2025 and bottomed at -$514.4 million in Q1 2023.
- Historically, Retained Earnings has averaged -$243.1 million across 5 years, with a median of -$339.0 million in 2021.
- On a YoY basis, Retained Earnings climbed as much as 5268344.44% in 2025 and fell as far as 264185.71% in 2025.
- Tectonic Therapeutic's Retained Earnings stood at -$383.5 million in 2021, then declined by 27.61% to -$489.4 million in 2022, then jumped by 101.22% to $6.0 million in 2023, then tumbled by 99.85% to $9000.0 in 2024, then jumped by 5268344.44% to $474.2 million in 2025.
- Business Quant data shows TECX's Retained Earnings at $474.2 million in Q4 2025, -$203.5 million in Q3 2025, and -$184.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | 494.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 494.11 Mn |
| Mar 31, 2026 | 478.39 Mn |
| Dec 31, 2025 | 474.16 Mn |
| Sep 30, 2025 | -203.50 Mn |
| Jun 30, 2025 | -184.50 Mn |
| Mar 31, 2025 | -164.49 Mn |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | -77,000.00 |
| Jun 30, 2024 | 284.92 Mn |
| Mar 31, 2024 | -484.08 Mn |
| Dec 31, 2023 | 5.98 Mn |
| Sep 30, 2023 | -468.49 Mn |
| Jun 30, 2023 | -446.91 Mn |
| Mar 31, 2023 | -514.39 Mn |
| Dec 31, 2022 | -489.43 Mn |
| Sep 30, 2022 | -464.40 Mn |
| Jun 30, 2022 | -441.43 Mn |
| Mar 31, 2022 | -413.38 Mn |
| Dec 31, 2021 | -383.54 Mn |
| Sep 30, 2021 | -355.32 Mn |